Sari Pesonen

Company: Valo Therapeutics
Job title: Co-Founder & Chief Scientific Officer
Seminars:
PeptiCRAd – Flexible Peptide Delivery Platform for Therapeutic Cancer (Neoantigen) Vaccines 4:00 pm
• Reviewing how the safety and efficacy of these vaccine modalities remains unclear in certain cancer patients • Addressing the complex manufacturing process and regulatory aspects • Developing neoantigen vaccines based on peptides and viral adjuvantsRead more
day: Day One